Related Experiment Video
Updated: Mar 3, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Representation is Prevention: Closing the Sex Gap in Novel Cardiovascular Clinical Trials
Nishant P Shah1, Martha Gulati2
1Associate Professor of Medicine in Cardiology, Duke University Medical Center, Duke Clinical Research Institute, United States.
No abstract available in PubMed .
More Related Videos
02:47Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Coronary Artery Disease III: Clinical Manifestations
Cardiovascular Drugs: Classification based on Therapeutic Indications